StockDrifts LogoStockDrifts

B Group 13F Portfolio

Portfolio Manager
B Group INC
Performance
+18.26% (2026 Q2)
AUM (13F)
$213.01M
# of Holdings
18
Performance Rank
N/A
Allocation (Top 20)
100.01%
Latest filing
Q2 2026

B Group INC Holdings Map

Top 18 B Group INC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
ADMA
ADMA BIOLOGICS INC
15.5%3.26M$27.3M
+1.71%(+55.00K)
2025-Q2: 2.32M shares2025-Q3: 2.41M shares2025-Q4: 2.46M shares2026-Q1: 3.21M shares2026-Q2: 3.26M shares
$17.18(-44.84%)
2026-06-30
PALI
PALISADE BIO INC
13.54%11.41M$23.9M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 4.50M shares2026-Q1: 11.41M shares2026-Q2: 11.41M shares
$1.87(+14.69%)
2026-06-30
NRXP
NRX PHARMACEUTICALS INC
9.5%4.09M$16.7M
+36.39%(+1.09M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 3.00M shares2026-Q2: 4.09M shares
$3.23(+3.43%)
2026-06-30
SNSE
FAETH THERAPEUTICS INC
8.66%610.2K$15.3Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 610.2K shares
$24.00(+8.17%)
2026-06-30
TSHA
TAYSHA GENE THERAPIES INC
6.96%1.80M$12.3M
+0.00%(+0)
2025-Q2: 1.80M shares2025-Q3: 1.80M shares2025-Q4: 1.80M shares2026-Q1: 1.80M shares2026-Q2: 1.80M shares
$1.90(+215.97%)
2026-06-30
PRAX
PRAXIS PRECISION MEDICINES I
6.32%33.2K$11.1M
+0.00%(+0)
2025-Q2: 35.0K shares2025-Q3: 31.5K shares2025-Q4: 33.2K shares2026-Q1: 33.2K shares2026-Q2: 33.2K shares
$56.11(+579.47%)
2026-06-30
CLLS
CELLECTIS S A
5.59%3.28M$9.8M
+0.00%(+0)
2025-Q2: 3.26M shares2025-Q3: 3.28M shares2025-Q4: 3.28M shares2026-Q1: 3.28M shares2026-Q2: 3.28M shares
$1.94(+64.06%)
2026-06-30
ZLAB
ZAI LAB LTD
4.86%450.6K$8.6M
+0.00%(+0)
2025-Q2: 400.0K shares2025-Q3: 400.0K shares2025-Q4: 400.0K shares2026-Q1: 450.6K shares2026-Q2: 450.6K shares
$24.39(+6.75%)
2026-06-30
GPCR
STRUCTURE THERAPEUTICS INC
4.26%140.0K$7.5M
+9.80%(+12.50K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 90.0K shares2026-Q1: 127.5K shares2026-Q2: 140.0K shares
$51.48(+6.25%)
2026-06-30
ORKA
ORUKA THERAPEUTICS INC
4.05%75.0K$7.1M
+0.00%(+0)
2025-Q2: 75.0K shares2025-Q3: 75.0K shares2025-Q4: 75.0K shares2026-Q1: 75.0K shares2026-Q2: 75.0K shares
$16.06(+557.40%)
2026-06-30

About B Group INCโ€™s portfolio

B Group INC reports $213.01M in US-listed equity holdings across 18 positions in its most recent 13F filing. Its largest disclosed positions are ADMA (15.5%), PALI (13.5%) and NRXP (9.5%). The top 20 holdings account for 100.01% of reported assets. Its disclosed equity book has returned +36.35% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
ADMA โ€” 15.5% ($27.31M)PALI โ€” 13.5% ($23.86M)NRXP โ€” 9.5% ($16.74M)SNSE โ€” 8.7% ($15.25M)TSHA โ€” 7.0% ($12.26M)PRAX โ€” 6.3% ($11.13M)CLLS โ€” 5.6% ($9.84M)ZLAB โ€” 4.9% ($8.56M)GPCR โ€” 4.3% ($7.51M)ORKA โ€” 4.1% ($7.14M)Other โ€” 20.8% ($36.59M)
79%in top 10
  • ADMA15.5%
  • PALI13.5%
  • NRXP9.5%
  • SNSE8.7%
  • TSHA7.0%
  • PRAX6.3%
  • CLLS5.6%
  • ZLAB4.9%
  • GPCR4.3%
  • ORKA4.1%
  • Other20.8%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
1
SNSEFAETH THERAPEUTICS INC8.7%
Added to
5
NRXPNRX PHARMACEUTICALS INC+36.4%
AURAAURA BIOSCIENCES INC+27.9%
GPCRSTRUCTURE THERAPEUTICS INC+9.8%
FHTXFOGHORN THERAPEUTICS INC+96.1%
+1 more
Trimmed
1
SYRESPYRE THERAPEUTICS INC-30.0%

Unlock alerts, watchlists & AI chat

Sign up free to track B Group INC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from B Group INCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2043476). View B Group INCโ€™s 13F filings on SEC

More 13F analyses

View all